Rankings
▼
Calendar
INSM Q4 2021 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena
INSM
Insmed Incorporated
$31B
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$56M
+35.5% YoY
Gross Profit
$43M
76.3% margin
Operating Income
-$99M
-176.5% margin
Net Income
-$113M
-201.3% margin
EPS (Diluted)
$-0.95
QoQ Revenue Growth
+20.0%
Cash Flow
Operating Cash Flow
-$84M
Free Cash Flow
-$85M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$833M
Stockholders' Equity
$410M
Cash & Equivalents
$717M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$56M
$41M
+35.5%
Gross Profit
$43M
$31M
+40.2%
Operating Income
-$99M
-$95M
-4.8%
Net Income
-$113M
-$102M
-10.5%
← FY 2021
All Quarters
Q1 2022 →